Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00409
|
|||||
Drug Name |
Bleomycin
|
|||||
Synonyms |
BLM; Blenoxane; Blenoxane (TN); Bleo; Bleocin; Bleogin; Bleomicin; Bleomicina; Bleomicina [INN-Spanish]; Bleomycin A(2); Bleomycin A2 & Bleomycin B2; Bleomycin B(2); Bleomycin a2; Bleomycin sulfate; Bleomycine; Bleomycine [INN-French]; Bleomycins; Bleomycinum; Bleomycinum [INN-Latin]; N(1)-[3-(dimethylsulfonio)propyl]bleomycinamide; N1-(3-(Dimethylsulfonio)propyl)bleomycinamide; NDC 0015-3010; Pingyangmyvin A2; Zhengguangmycin A2; Zhengguangmycin A2 [Chinese]
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Anticancer Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C55H84N17O21S3+
|
|||||
Canonical SMILES |
CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O
|
|||||
InChI |
InChI=1S/C55H83N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81H,7-13,15-16,56H2,1-6H3,(H13-,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88)/p+1/t21-,22+,23+,24-,25-,29?,30?,34-,35-,36-,37?,38?,39?,40?,41-,42?,43?,53?,54?/m0/s1
|
|||||
InChIKey |
OYVAGSVQBOHSSS-WXFSZRTFSA-O
|
|||||
CAS Number |
CAS 11056-06-7
|
|||||
Pharmaceutical Properties | Molecular Weight | 1415.6 | Topological Polar Surface Area | 685 | ||
Heavy Atom Count | 96 | Rotatable Bond Count | 36 | |||
Hydrogen Bond Donor Count | 20 | Hydrogen Bond Acceptor Count | 31 | |||
XLogP |
-7.5
|
|||||
PubChem CID | ||||||
PubChem SID | ||||||
ChEBI ID |
ChEBI:3139
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.